Femtech is a term used for female technology which involves the use of digital health tools including software, diagnostics, products, and services that are targeted at women’s health. According to a recent Future Market Insights (FMI) report, the global femtech market is estimated to hit a valuation of US$ 948.1 Mn.
On April 30, 2021, the shares in Papilly AB (publ) (the "Company") (under name
change to Bonzun AB (publ)) were given observation status after the Company had
entered into a letter of intent to acquire
The FMI survey conducted on the femtech market offers insights into key drivers and restraints affecting the market growth. The report offers a comprehensive femtech demand outlook and identifies
Nasdaq Stockholm AB: Papilly AB (publ) receives observation status (191/21)
On April 16, 2021, Papilly AB (publ) (the Company ) published a press release
with information that the Company had entered into a letter of intent to
acquire Bonzun Health Information AB.
On April 29, 2021, the Company published a press release with information that
it, because of the planned acquisition, will be subject to an examination by
Nasdaq Stockholm AB (the Exchange ) comparable to that conducted for an
entirely new issuer applying for admission to trading, after which the Exchange
will decide whether to admit the Company s shares for continued trading on
Nasdaq First North Growth Market.